CClinicalTrials.gg
CompletedNCT03371446Updated Dec 13, 2017

DNA Methylation Profile of the SOCS-1 Gene Promoter in Smokers Patients With Chronic Periodontitis.

An observational study in Periodontal Diseases and Epigenetics, sponsored by University of Sao Paulo. Completed at 1 site in Brazil. Open to participants aged 30 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-12-13.

Sponsored by University of Sao Paulo · Observational

Study type
Observational
Model
Case-control
Time perspective
Other
Enrollment
60
Ages
30 Years and older
Sex
All
01

Study summary

Periodontitis is related to host genetics, constitution of the dental biofilm and environmental factors such as smoking. DNA methylation is a mechanism of genetic expression that can inhibit or silence gene expression. In this way several researchers have been dedicated to study the genetic influence on the susceptibility and / or increased risk to periodontal disease. Studies have reported association between several epigenetic biomarkers with periodontal inflammation. Considering the hypothesis that there is an association between smoking and methylation in genes related to periodontal disease, the objective of this study was to verify the DNA methylation pattern in oral epithelial cells of patients with chronic periodontitis (CP) in the promoter of a specific gene involved in the control of inflammation, as suppressor of cytokine signaling (SOCS) 1 in smokers and nonsmokers patients.

Read the detailed description

This was an experimental type study with parallel controls, comparing two groups, a group with consumption of 10 minimum cigarettes per day, with a diagnosis of chronic periodontitis. And another control group were non-smokers with chronic periodontitis. For this, genomic DNA was purified from oral epithelial cells obtained by rinsing with 3% sucrose, for a single time of collection, patients received periodontal treatment after collection and data analysis. The DNA was modified by Sodium bisulfite and the methylation patterns of the DNA were analyzed with the MSPCR technique (Polymerase chain reaction). This study was approved by the Institutional Review Board of the School of Dentistry of Ribeirão Preto (CAAE:57171816.2.0000.5419 ), and all patients need to provide written informed consent.

02

Conditions studied

  • Periodontal Diseases
  • Epigenetics

Keywords

  • DNA Methylation. Smoking. SOCS-1 gene.
03

Who can participate

Ages eligible
30 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients who smoked for more than 10 years, consuming 10 more cigarettes per day and diagnosing chronic periodontitis (case) and another group (control) were non-smokers with chronic periodontitis, according to the standard of WHO definition of the smoking population,The ChP was diagnose in accordance with the recommended standards from the Center for Disease control and Prevention, the American Academy of Periodontology on the condition of patients in good general health, aged over 30 years, presenting with pocket periodontal disease with CAL ≥ 5 mm and radiographic bone loss and bleeding after probing.

Inclusion criteria

  • Chronic Periodontitis carriers - presence of proximal insertion loss ≥5 mm in more than 30% of the teeth present.
  • Periodontal pocket ≥ 5mm
  • Smokers who have smoked 10 or more cigarettes per day for the past five years.
  • No positive history of basic periodontal treatment in the last six months.

Exclusion criteria

Exclusion Criteria:

  • Extensive prosthetic involvement.
  • Using anti-inflammatories.
  • Pregnant or nursing.
  • Presence of systemic alterations that compromise host response or require prophylactic medication for treatment.
  • History of constant use of oral antiseptics in the last six months.
04

Study design

Observational model
Case-control
Time perspective
Other
Enrollment
60 participants (actual)
Patient registry
No
Biospecimen retention
Samples with dna

Groups and cohorts

  • Smokers/Non-smokers

    It was an experimental study with parallel controls, comparing two groups, a group with patients who smoked for more than 10 years, consuming 10 more cigarettes per day and diagnosing chronic periodontitis (case) and another group (control) were non-smokers with chronic periodontitis, according to the standard of World Health Organization (WHO) definition of the smoking population

    Genetic: oral epithelial cells obtained by rinsing with 3% sucrose

Interventions

  • Geneticoral epithelial cells obtained by rinsing with 3% sucrose

    rinsing with 3% sucrose, for a single time of collection, patients received periodontal treatment after collection and data analysis.

05

What researchers measure

Primary outcomes

  1. Extraction of genomic DNA from oral epithelial cells

    Epithelial cells were collected after mouthwash with 5ml dextrose autoclaved 3% and stored under refrigeration at -20ºC. After collection, the samples were taken to the Epigenetics and Reproduction Laboratory of the Department of Genetics of the Medical School of Ribeirão Preto-USP (FMRP-USP) where nucleic acid extraction and molecular analysis were performed. After thawing the saliva, 2ml of each sample collected were transferred separately to eppendorf tubes, for processing. The material was then diluted in 50 μl of cobalt Mili-Q water, incubated at 37 ° C in a water bath for 1 hour and stored in a freezer at -20 ° C. At the end, DNA quality, purity and integrity were measured using a spectrophotometer (NanoDrop 2000-Thermo Scientific), using OD 260/280 and 260/230. Considering ideal values for both reasons, between 1.8 and 2.2.

    Time frame: Baseline (at the beginning of the study)

Secondary outcomes

  1. Probing pocket depth (PD)

    Clinical parameter was recorded at baseline by one trained periodontist.Probing pocket depth (PD) was measured from the free gingival margin to the bottom of the periodontal pocket and clinical attachment level ( CAL) was measured from the cementum-enamel junction (CEJ) to the bottom of periodontal pocket. Probing measurement was performed using a manual University of North Carolina - UNC Periodontal probe (Hu- Friedy, Chicago, IL, USA).

    Time frame: Baseline (at the beginning of the study)

  2. Plaque index (PI)

    Clinical parameter was recorded at baseline by one trained periodontist. Plaque index (PI) was used to assess the oral hygiene status of the patients, the evaluation was done with the unit of measure in percentage (%) whole mouth. Probing measurement was performed using a manual University of North Carolina - UNC Periodontal probe (Hu- Friedy, Chicago, IL, USA).

    Time frame: Baseline (at the beginning of the study)

  3. Bleeding on probing (BOP)

    Clinical parameter was recorded at baseline by one trained periodontist.Bleeding on probing (BOP) was recorded based on the presence or absence of bleeding up to 30 seconds after probing on four sides of each tooth,the evaluation was done with the unit of measure in percentage (%) whole mouth. Probing measurement was performed using a manual University of North Carolina - UNC Periodontal probe (Hu- Friedy, Chicago, IL, USA).

    Time frame: Baseline (at the beginning of the study)

06

Study locations

1 site
  • Arthur Belem Novaes Junior
    Ribeirão Preto, SP 14040-904, Brazil
07

References and documents

Individual participant data

Plan to share: Yes — Individual participant data will be made available with conclusion of study.

Supporting information: Study protocol

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03371446
Lead sponsor
University of Sao Paulo
Responsible party
Arthur Belem Novaes Jr (Teacher of Periodontia- Department of Buco Maxillofacial Surgery and Traumatology and Periodontics, University of Sao Paulo) — Principal investigator
First posted
Dec 13, 2017
Start date
Jun 6, 2016
Primary completion
Oct 16, 2017
Completion
Nov 18, 2017
Last update
Dec 13, 2017

Study contacts

Arthur B. Novaes Junior, DDS, PhD
principal investigator · Study Principal Investigator

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion